NewsMarkets

Health

US-Backed Hepatitis B Vaccine Trial Cancelled in Guinea-Bissau

Guinea-Bissau cancels the controversial trial after rejecting the design as unethical and neocolonial.

2 publishers · 2 articles · first seen 5 Nov 2026 · updated 2h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 5 Nov 2026. BBC Health published first, on 5 November at 00:30 UTC; businessinsider.com followed 7h 22m later. The most recent article, from businessinsider.com, appeared on 5 November at 07:52 UTC.

Outlets reporting it: BBC Health, businessinsider.com.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. A controversial US-backed $1.6 million vaccine trial involving 14,000 newborns in West Africa has been cancelled businessinsider.com
  2. Why a US-funded vaccine trial on babies was cancelled in Guinea-Bissau BBC Health

In this story

Embed this story

Paste this into any web page to show the live odds, with a link back here.